Search

Gerald R. Ewoldt

Examiner (ID: 4358, Phone: (571)272-0843 , Office: P/1644 )

Most Active Art Unit
1644
Art Unit(s)
1644
Total Applications
1060
Issued Applications
256
Pending Applications
142
Abandoned Applications
661

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 6080178 [patent_doc_number] => 20110142866 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-16 [patent_title] => 'PEPTIDE ANALOGUES AND CONJUGATES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/743975 [patent_app_country] => US [patent_app_date] => 2008-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 32414 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20110142866.pdf [firstpage_image] =>[orig_patent_app_number] => 12743975 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/743975
PEPTIDE ANALOGUES AND CONJUGATES THEREOF Nov 19, 2008 Abandoned
Array ( [id] => 6520039 [patent_doc_number] => 20100261887 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-14 [patent_title] => 'TACI-IMMUNOGLOBULIN FUSION PROTEINS FOR TREATMENT OF RELAPSING MULTIPLE SCLEROSIS' [patent_app_type] => utility [patent_app_number] => 12/740421 [patent_app_country] => US [patent_app_date] => 2008-11-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 18710 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0261/20100261887.pdf [firstpage_image] =>[orig_patent_app_number] => 12740421 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/740421
TACI-IMMUNOGLOBULIN FUSION PROTEINS FOR TREATMENT OF RELAPSING MULTIPLE SCLEROSIS Nov 10, 2008 Abandoned
Array ( [id] => 8406392 [patent_doc_number] => 20120238460 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-20 [patent_title] => 'RANTES LEVELS AS A DIAGNOSTIC AND THERAPEUTIC FOR ACUTE GRAFT VERSUS HOST DISEASE' [patent_app_type] => utility [patent_app_number] => 12/739976 [patent_app_country] => US [patent_app_date] => 2008-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 15253 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12739976 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/739976
RANTES LEVELS AS A DIAGNOSTIC AND THERAPEUTIC FOR ACUTE GRAFT VERSUS HOST DISEASE Nov 9, 2008 Abandoned
Array ( [id] => 6292581 [patent_doc_number] => 20100239580 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-23 [patent_title] => 'TACI-IMMUNOGLOBULIN FUSION PROTEINS FOR TREATMENT OF OPTIC NEURITIS' [patent_app_type] => utility [patent_app_number] => 12/740879 [patent_app_country] => US [patent_app_date] => 2008-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 14985 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0239/20100239580.pdf [firstpage_image] =>[orig_patent_app_number] => 12740879 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/740879
TACI-IMMUNOGLOBULIN FUSION PROTEINS FOR TREATMENT OF OPTIC NEURITIS Nov 9, 2008 Abandoned
Array ( [id] => 5342387 [patent_doc_number] => 20090181037 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-16 [patent_title] => 'Semi-Synthetic GLP-1 Peptide-FC Fusion Constructs, Methods and Uses' [patent_app_type] => utility [patent_app_number] => 12/263738 [patent_app_country] => US [patent_app_date] => 2008-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 20816 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0181/20090181037.pdf [firstpage_image] =>[orig_patent_app_number] => 12263738 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/263738
Semi-Synthetic GLP-1 Peptide-FC Fusion Constructs, Methods and Uses Nov 2, 2008 Abandoned
Array ( [id] => 6024243 [patent_doc_number] => 20110052569 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-03 [patent_title] => 'MOLECULES AND METHODS FOR TREATMENT OF DIABETES' [patent_app_type] => utility [patent_app_number] => 12/676776 [patent_app_country] => US [patent_app_date] => 2008-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 17676 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0052/20110052569.pdf [firstpage_image] =>[orig_patent_app_number] => 12676776 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/676776
MOLECULES AND METHODS FOR TREATMENT OF DIABETES Sep 5, 2008 Abandoned
Array ( [id] => 5953227 [patent_doc_number] => 20110033929 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-10 [patent_title] => 'USES OF ANTIBODIES TO MAMMALIAN DC LANGERHANS CELL ANTIGEN' [patent_app_type] => utility [patent_app_number] => 12/202701 [patent_app_country] => US [patent_app_date] => 2008-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23983 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0033/20110033929.pdf [firstpage_image] =>[orig_patent_app_number] => 12202701 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/202701
USES OF ANTIBODIES TO MAMMALIAN DC LANGERHANS CELL ANTIGEN Sep 1, 2008 Abandoned
Array ( [id] => 6266440 [patent_doc_number] => 20100298227 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-25 [patent_title] => ' Treatment of autoimmune conditions with Copolymer 1 and related copolymers' [patent_app_type] => utility [patent_app_number] => 12/231292 [patent_app_country] => US [patent_app_date] => 2008-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 17544 [patent_no_of_claims] => 176 [patent_no_of_ind_claims] => 38 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20100298227.pdf [firstpage_image] =>[orig_patent_app_number] => 12231292 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/231292
Treatment of autoimmune conditions with Copolymer 1 and related copolymers Aug 28, 2008 Abandoned
Array ( [id] => 6402926 [patent_doc_number] => 20100179307 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-15 [patent_title] => 'BIOMAKER COMPOSITION FOR DETECTING DIABETIC RETINOPATHY AND DIAGNOSTIC KIT THEREFOR' [patent_app_type] => utility [patent_app_number] => 12/733330 [patent_app_country] => US [patent_app_date] => 2008-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 19381 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0179/20100179307.pdf [firstpage_image] =>[orig_patent_app_number] => 12733330 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/733330
BIOMAKER COMPOSITION FOR DETECTING DIABETIC RETINOPATHY AND DIAGNOSTIC KIT THEREFOR Aug 27, 2008 Abandoned
Array ( [id] => 5323485 [patent_doc_number] => 20090061475 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-05 [patent_title] => 'Methods for Identifying Compounds for the Treatment of Type 1 Diabetes' [patent_app_type] => utility [patent_app_number] => 12/196543 [patent_app_country] => US [patent_app_date] => 2008-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7029 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0061/20090061475.pdf [firstpage_image] =>[orig_patent_app_number] => 12196543 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/196543
Methods for Identifying Compounds for the Treatment of Type 1 Diabetes Aug 21, 2008 Abandoned
Array ( [id] => 4778283 [patent_doc_number] => 20080286281 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-20 [patent_title] => 'CD25 BINDING MOLECULES FOR THE USE IN THE TREATMENT OF MANIFESTATIONS OF REJECTION IN TRANSPLANTATION' [patent_app_type] => utility [patent_app_number] => 12/180660 [patent_app_country] => US [patent_app_date] => 2008-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2468 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20080286281.pdf [firstpage_image] =>[orig_patent_app_number] => 12180660 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/180660
CD25 BINDING MOLECULES FOR THE USE IN THE TREATMENT OF MANIFESTATIONS OF REJECTION IN TRANSPLANTATION Jul 27, 2008 Abandoned
Array ( [id] => 5441413 [patent_doc_number] => 20090093052 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-09 [patent_title] => 'Human Hematopoietic Stem And Progenitor Antigen And Methods For Its Use' [patent_app_type] => utility [patent_app_number] => 12/169336 [patent_app_country] => US [patent_app_date] => 2008-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 14452 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20090093052.pdf [firstpage_image] =>[orig_patent_app_number] => 12169336 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/169336
Composition comprising a cell expressing an AC133 cell surface antigen and an antibody or antigen-binding fragment Jul 7, 2008 Issued
Array ( [id] => 10882006 [patent_doc_number] => 08906383 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-12-09 [patent_title] => 'T cell receptor having binding affinity for a peptide-MHC complex and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/666416 [patent_app_country] => US [patent_app_date] => 2008-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 17 [patent_no_of_words] => 15062 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12666416 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/666416
T cell receptor having binding affinity for a peptide-MHC complex and uses thereof Jun 26, 2008 Issued
Array ( [id] => 5575430 [patent_doc_number] => 20090142792 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-04 [patent_title] => 'Biomarkers for the diagnosis of autoimmune disease' [patent_app_type] => utility [patent_app_number] => 12/214670 [patent_app_country] => US [patent_app_date] => 2008-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 22026 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20090142792.pdf [firstpage_image] =>[orig_patent_app_number] => 12214670 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/214670
Biomarkers for the diagnosis of autoimmune disease Jun 19, 2008 Abandoned
Array ( [id] => 6228859 [patent_doc_number] => 20100183597 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-22 [patent_title] => 'DRAK2 EXPRESSION IS ASSOCIATED WITH DIABETES' [patent_app_type] => utility [patent_app_number] => 12/602893 [patent_app_country] => US [patent_app_date] => 2008-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 36 [patent_no_of_words] => 25834 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20100183597.pdf [firstpage_image] =>[orig_patent_app_number] => 12602893 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/602893
DRAK2 EXPRESSION IS ASSOCIATED WITH DIABETES Jun 5, 2008 Abandoned
Array ( [id] => 5507920 [patent_doc_number] => 20090081127 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-26 [patent_title] => 'Dendritic-like cell/tumor cell hybrids and hybridomas for inducing an anti-tumor response' [patent_app_type] => utility [patent_app_number] => 12/154939 [patent_app_country] => US [patent_app_date] => 2008-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 17891 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20090081127.pdf [firstpage_image] =>[orig_patent_app_number] => 12154939 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/154939
Dendritic-like cell/tumor cell hybrids and hybridomas for inducing an anti-tumor response May 26, 2008 Abandoned
Array ( [id] => 6479316 [patent_doc_number] => 20100285146 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-11 [patent_title] => 'PEPTIDES AND METHODS FOR THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS' [patent_app_type] => utility [patent_app_number] => 12/601261 [patent_app_country] => US [patent_app_date] => 2008-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 7697 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0285/20100285146.pdf [firstpage_image] =>[orig_patent_app_number] => 12601261 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/601261
PEPTIDES AND METHODS FOR THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS May 21, 2008 Abandoned
Array ( [id] => 6577282 [patent_doc_number] => 20100047273 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-25 [patent_title] => 'Coxsackie B virus and type 1 diabetes' [patent_app_type] => utility [patent_app_number] => 12/151725 [patent_app_country] => US [patent_app_date] => 2008-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 11969 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0047/20100047273.pdf [firstpage_image] =>[orig_patent_app_number] => 12151725 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/151725
Coxsackie B virus and type 1 diabetes May 6, 2008 Abandoned
Array ( [id] => 13635305 [patent_doc_number] => 09844602 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-12-19 [patent_title] => Antibody and use in diagnosis and therapy of arthropathies [patent_app_type] => utility [patent_app_number] => 12/598671 [patent_app_country] => US [patent_app_date] => 2008-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 9819 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12598671 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/598671
Antibody and use in diagnosis and therapy of arthropathies May 1, 2008 Issued
Array ( [id] => 6550509 [patent_doc_number] => 20100233183 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-16 [patent_title] => 'CYTOTOXIC ANTI-LAG-3 MONOCLONAL ANTIBODY AND ITS USE IN THE TREATMENT OR PREVENTION OF ORGAN TRANSPLANT REJECTION AND AUTOIMMUNE DISEASE' [patent_app_type] => utility [patent_app_number] => 12/598128 [patent_app_country] => US [patent_app_date] => 2008-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 8135 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0233/20100233183.pdf [firstpage_image] =>[orig_patent_app_number] => 12598128 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/598128
CYTOTOXIC ANTI-LAG-3 MONOCLONAL ANTIBODY AND ITS USE IN THE TREATMENT OR PREVENTION OF ORGAN TRANSPLANT REJECTION AND AUTOIMMUNE DISEASE Apr 29, 2008 Abandoned
Menu